Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES SUN PHARMA DIVIS LABORATORIES/
SUN PHARMA
 
P/E (TTM) x 29.8 58.5 50.9% View Chart
P/BV x 7.6 5.2 146.3% View Chart
Dividend Yield % 0.9 1.0 92.9%  

Financials

 DIVIS LABORATORIES   SUN PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
SUN PHARMA
Mar-22
DIVIS LABORATORIES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs5,425931 582.8%   
Low Rs3,562593 601.1%   
Sales per share (Unadj.) Rs337.5161.1 209.5%  
Earnings per share (Unadj.) Rs111.514.2 785.6%  
Cash flow per share (Unadj.) Rs123.323.1 532.9%  
Dividends per share (Unadj.) Rs30.0010.00 300.0%  
Avg Dividend yield %0.71.3 50.9%  
Book value per share (Unadj.) Rs441.8200.1 220.8%  
Shares outstanding (eoy) m265.472,399.34 11.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.34.7 281.6%   
Avg P/E ratio x40.353.7 75.1%  
P/CF ratio (eoy) x36.532.9 110.7%  
Price / Book Value ratio x10.23.8 267.2%  
Dividend payout %26.970.4 38.2%   
Avg Mkt Cap Rs m1,192,8901,827,693 65.3%   
No. of employees `000NANA-   
Total wages/salary Rs m9,46273,008 13.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,598386,545 23.2%  
Other income Rs m1,15914,374 8.1%   
Total revenues Rs m90,757400,919 22.6%   
Gross profit Rs m38,81153,150 73.0%  
Depreciation Rs m3,11521,437 14.5%   
Interest Rs m201,274 1.6%   
Profit before tax Rs m36,83544,813 82.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,23110,755 67.2%   
Profit after tax Rs m29,60534,058 86.9%  
Gross profit margin %43.313.7 315.0%  
Effective tax rate %19.624.0 81.8%   
Net profit margin %33.08.8 375.0%  
BALANCE SHEET DATA
Current assets Rs m96,104350,150 27.4%   
Current liabilities Rs m24,544172,006 14.3%   
Net working cap to sales %79.946.1 173.3%  
Current ratio x3.92.0 192.3%  
Inventory Days Days9149 5.8%  
Debtors Days Days987100 987.2%  
Net fixed assets Rs m50,087318,882 15.7%   
Share capital Rs m5312,399 22.1%   
"Free" reserves Rs m116,751477,713 24.4%   
Net worth Rs m117,282480,112 24.4%   
Long term debt Rs m02,299 0.0%   
Total assets Rs m146,191669,032 21.9%  
Interest coverage x1,842.836.2 5,092.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.6 106.1%   
Return on assets %20.35.3 383.7%  
Return on equity %25.27.1 355.8%  
Return on capital %31.49.6 328.9%  
Exports to sales %00-   
Imports to sales %19.70-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m17,676NA-   
Fx inflow Rs m78,445106,331 73.8%   
Fx outflow Rs m17,95371,874 25.0%   
Net fx Rs m60,49234,456 175.6%   
CASH FLOW
From Operations Rs m19,11889,845 21.3%  
From Investments Rs m-21,949-57,247 38.3%  
From Financial Activity Rs m-5,324-51,935 10.3%  
Net Cashflow Rs m-8,156-17,648 46.2%  

Share Holding

Indian Promoters % 51.9 54.5 95.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 35.6 101.5%  
FIIs % 15.4 16.0 96.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 45.5 105.6%  
Shareholders   379,257 643,512 58.9%  
Pledged promoter(s) holding % 0.0 2.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Divis Laboratories vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Sun Pharma Share Price Performance

Period Divis Laboratories Sun Pharma S&P BSE HEALTHCARE
1-Day -1.85% -0.66% -0.39%
1-Month -11.21% -1.19% -2.28%
1-Year -29.74% 35.64% -5.89%
3-Year CAGR 23.42% 33.17% 20.85%
5-Year CAGR 26.59% 14.81% 11.41%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

Sun Pharma paid Rs 10.0, and its dividend payout ratio stood at 70.4%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.